Arthex Biotech News and Activities

Acquisition, funding and merger involving Arthex Biotech.

• Arthex Biotech has just announced a $87 Million fundraising (posted on September 18 2025).

View the org chart displaying its 13 main executives

Most searched biographies at Arthex Biotech

• Frederic Legros, Chief Executive Officer and Chairman of the Board
• Jose Mesa, Board Member
• Muthiah Manoharan, Director

Create your alert
to follow the executive moves at Arthex Biotech.

Arthex Biotech has 2,424 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• The new name of EG 427 is Cyllene Therapeutics. (posted on July 10 2026).
• Opthea will change its company name to Ceryvyn Therapeutics on Jul 9, 2026. (posted on July 9 2026).
• Tissium has just announced a $60 Million fundraising (posted on July 8 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by Arthex Biotech

• News & Events | Chardan

Social media about Arthex Biotech

• Arthex Biotech on Wikipedia, Google News & Yahoo Finance
• Arthex Biotech on LinkedIn, X (Twitter) & YouTube